The combination of insulin and metformin in treatment of non-insulin-dependent diabetes mellitus.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
A ChaudhuriP Dandona

Abstract

To assess whether, in the treatment of non-insulin-dependent diabetes mellitus (NIDDM), (1) metformin in conjunction with insulin can safely cause a decrease in glycosylated hemoglobin (HbA1c) to 7% or less and (2) this combination therapy may result in weight loss and lower insulin dose in comparison with insulin treatment alone. Forty patients with NIDDM being treated with insulin on their first visit to the Diabetes Center were identified by retrospective review of medical records of all patients encountered during a 1-year period. These patients were classified into groups who were receiving insulin only (group 1) or insulin + metformin (group 2) at the most recent visit. Group 2 was subdivided into those with a body mass index of either =30 kg/m 2 (group 2A) or >30 kg/m 2 (group 2B). Blood glucose, HbA1c, insulin dose, and weights were analyzed from their initial and most recent visits. HbA1c decreased from 10 +/- 2.7% to 7 +/- 1.1% (P<0.01) in group 1 and from 9.8 +/- 2.1% to 7.2 +/- 1.4% (P<0.01) in group 2. The magnitude of decrease in HbA1c, however, was not different between the two groups. Total insulin dose increased from 40 (33 to 50) U/day to 58 (41 to 67) U/day (P<0.05) in group 1 and from 63 (42 to 118) U/day to...Continue Reading

References

Jun 1, 1992·Diabetes Care·C J Bailey
Dec 1, 1991·The Journal of Clinical Endocrinology and Metabolism·R A DeFronzoD C Simonson
Sep 1, 1983·Diabetes Care·P DandonaA G Beckett
Feb 9, 1984·The New England Journal of Medicine·D M NathanJ D Goodson
Aug 31, 1995·The New England Journal of Medicine·M StumvollJ E Gerich
Sep 14, 1995·The New England Journal of Medicine·T Byers
Sep 1, 1995·Metabolism: Clinical and Experimental·J P Deslypere
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Feb 29, 1996·The New England Journal of Medicine·C J Bailey, R C Turner

❮ Previous
Next ❯

Citations

Jan 1, 2008·International Journal of Diabetes in Developing Countries·Rashmi JainM Kabadi
Oct 30, 2007·The Medical Clinics of North America·Denise Joffe, Robert T Yanagisawa
Jan 13, 2006·Diabetes Research and Clinical Practice·Udaya M Kabadi, Mary Kabadi
Oct 21, 2003·The Annals of Pharmacotherapy·Mary U Kabadi, Udaya M Kabadi
Nov 17, 2005·The Diabetes Educator·Susan NielsenParesh Dandona
Jun 23, 2001·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·K S Hershon, P M Hershon
May 14, 2010·Postgraduate Medicine·Annie A MavianRobert R Henry

❮ Previous
Next ❯

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

© 2022 Meta ULC. All rights reserved